REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q3 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,450 | -19.8% | 29,918 | -2.6% | 0.00% | – |
| Q2 2023 | $614,133 | -9.6% | 30,722 | -14.5% | 0.00% | – |
| Q1 2023 | $679,549 | -9.6% | 35,936 | +8.4% | 0.00% | – |
| Q4 2022 | $751,865 | +142.5% | 33,151 | +182.3% | 0.00% | – |
| Q3 2022 | $310,000 | -67.7% | 11,745 | -59.4% | 0.00% | – |
| Q1 2022 | $959,000 | -33.9% | 28,900 | -34.9% | 0.00% | – |
| Q4 2021 | $1,451,000 | -87.6% | 44,394 | -84.1% | 0.00% | -100.0% |
| Q3 2021 | $11,731,000 | +512.9% | 279,849 | +468.1% | 0.00% | – |
| Q2 2021 | $1,914,000 | +192.2% | 49,259 | +156.5% | 0.00% | – |
| Q1 2021 | $655,000 | -84.4% | 19,203 | -79.3% | 0.00% | -100.0% |
| Q4 2020 | $4,210,000 | +197.1% | 92,795 | +80.3% | 0.00% | +100.0% |
| Q3 2020 | $1,417,000 | +492.9% | 51,479 | +692.0% | 0.00% | – |
| Q2 2020 | $239,000 | +6.2% | 6,500 | +2.8% | 0.00% | – |
| Q3 2019 | $225,000 | -73.1% | 6,320 | -43.0% | 0.00% | -100.0% |
| Q3 2018 | $837,000 | +75.8% | 11,081 | -23.3% | 0.00% | 0.0% |
| Q3 2017 | $476,000 | – | 14,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
| MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
| Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
| ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
| Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
| MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
| WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
| Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
| SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
| Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |